We assisted PCAS in selling the pharmaceutical contract manufacturer Créapharm to Unither
AEC Partners was mandated by PCAS to sell its 50% stake in Créapharm
Creapharm is a pharmaceutical contract manufacturer which produces mostly effervescent and plain tablets as well as suppositories and ovules
It also offers services for galenic and analytical development, pilot batches and stability studies
The company was sold to Unither, a firm controlled by SG Capital Europe
Unither is a pharmaceutical contract manufacturer of sterile unit-dose vials using Blow-Fill & Seal machines
